Qianjiang Yongan Pharmaceutical Co Ltd (002365) — Cash Flow Reinvestment Rate
Qianjiang Yongan Pharmaceutical Co Ltd (002365) has a Cash Flow Reinvestment Rate of 0.20x as of September 2025, reinvesting CN¥11.85 Million (capex CN¥11.85 Million ) from operating cash flow of CN¥58.18 Million. Explore capital reinvestment ratio of Qianjiang Yongan Pharmaceutical Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Qianjiang Yongan Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2006–2024)
Historical reinvestment intensity for Qianjiang Yongan Pharmaceutical Co Ltd across 19 annual periods. Also explore 002365 asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Qianjiang Yongan Pharmaceutical Co Ltd (2006–2024)
Year-by-year capital reinvestment analysis for Qianjiang Yongan Pharmaceutical Co Ltd. For live market cap and broader valuation context, see how much is Qianjiang Yongan Pharmaceutical Co Ltd worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.77x | CN¥186.81 Million | CN¥105.71 Million | CN¥118.04 Million | ▲ +128.2% |
| 2023 | 0.77x | CN¥189.15 Million | CN¥244.26 Million | CN¥120.74 Million | ▲ +16.4% |
| 2022 | 0.67x | CN¥257.76 Million | CN¥387.28 Million | CN¥149.07 Million | ▼ -58.9% |
| 2021 | 1.62x | CN¥165.02 Million | CN¥101.81 Million | CN¥63.05 Million | ▼ -4.6% |
| 2020 | 1.70x | CN¥351.06 Million | CN¥206.66 Million | CN¥104.41 Million | ▲ +98.9% |
| 2019 | 0.85x | CN¥204.59 Million | CN¥239.55 Million | CN¥134.39 Million | ▼ -38.0% |
| 2018 | 1.38x | CN¥432.37 Million | CN¥314.02 Million | CN¥269.50 Million | ▼ -11.4% |
| 2017 | 1.55x | CN¥306.65 Million | CN¥197.32 Million | CN¥289.47 Million | ▲ +29.0% |
| 2016 | 1.20x | CN¥101.83 Million | CN¥84.53 Million | CN¥40.13 Million | ▲ +149.3% |
| 2015 | 0.48x | CN¥34.12 Million | CN¥70.61 Million | CN¥34.12 Million | ▼ -81.6% |
| 2014 | 2.63x | CN¥50.69 Million | CN¥19.26 Million | CN¥50.69 Million | ▲ +67.6% |
| 2013 | 1.57x | CN¥99.93 Million | CN¥63.65 Million | CN¥99.93 Million | ▼ -7.6% |
| 2012 | 1.70x | CN¥120.18 Million | CN¥70.75 Million | CN¥120.18 Million | ▼ -37.5% |
| 2011 | 2.72x | CN¥248.03 Million | CN¥91.23 Million | CN¥248.03 Million | ▲ +14.6% |
| 2010 | 2.37x | CN¥104.52 Million | CN¥44.06 Million | CN¥104.52 Million | ▲ +87.9% |
| 2009 | 1.26x | CN¥45.98 Million | CN¥36.43 Million | CN¥45.98 Million | ▲ +177.0% |
| 2008 | 0.46x | CN¥72.19 Million | CN¥158.47 Million | CN¥72.19 Million | ▼ -54.2% |
| 2007 | 0.99x | CN¥60.77 Million | CN¥61.08 Million | CN¥60.77 Million | ▲ +75.1% |
| 2006 | 0.57x | CN¥17.68 Million | CN¥31.11 Million | CN¥17.68 Million | — |